1 – 10 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Survival patterns after perioperative treatment escalation and cystectomy for synchronous oligometastatic bladder cancer (M1a/M1b) – a population-based series
- Contribution to journal › Article
-
Mark
Inter-reader agreement of quantitative FDG PET/CT biomarkers in lymphoma : a multicentre evaluation of MTV, TLG and Dmax
- Contribution to journal › Article
-
Mark
Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT : a comparison to MRI using histopathology as reference
- Contribution to journal › Article
-
Mark
Evaluation of [18F]PSMA-1007 uptake variability in patients with prostate cancer
- Contribution to journal › Article
-
Mark
AI based automatic measurement of split renal function in [18F]PSMA-1007 PET/CT
- Contribution to journal › Article
-
Mark
A fully automated AI-based method for tumour detection and quantification on [18F]PSMA-1007 PET–CT images in prostate cancer
- Contribution to journal › Article
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
- Contribution to journal › Article
-
Mark
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) : Results from an International Multicentre Registry Study
- Contribution to journal › Article
-
Mark
High concordance of PET-CT treatment response evaluation according to PERCIST 1.0 when comparing images reconstructed with OSEM vs. BSREM
- Contribution to journal › Article
-
Mark
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of systolic function during breast cancer therapy
- Contribution to journal › Article
